We are live on ! Find out more
TCM

Tamarack Capital Management Portfolio holdings

AUM $840M
1-Year Est. Return 19.47%
This Fund
S&P 500
This Quarter Est. Return
-9.37%
1 Year Est. Return
+19.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$840M
AUM Growth
-$29.6M
Cap. Flow
+$55.4M
Cap. Flow %
6.59%
Top 10 Hldgs %
70.69%
Holding
42
New
7
Increased
11
Reduced
10
Closed
10

Top Buys

Rank Stock Value
1
PDCO
Patterson Companies, Inc.
PDCO
+$17.7M
2
MDT icon
Medtronic
MDT
+$14.7M
3
AMGN icon
Amgen
AMGN
+$11.8M
4
CORI
Corium International, Inc.
CORI
+$7.25M
5
IMPR
IMPRIVATA, INC COM
IMPR
+$7.15M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$17.9M
2
MDXG icon
MiMedx Group
MDXG
+$15.1M
3
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$11.6M
4
BRKR icon
Bruker
BRKR
+$10.2M
5
ICUI icon
ICU Medical
ICUI
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 50.91%
2 Technology 3.01%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$134M 15.97%
700,000
+100,000
+17% +$20.3M
TLT icon
2
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$94.1M 11.21%
+762,000
New +$92.5M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$65.5M 7.8%
600,000
+100,000
+20% +$11.9M
PDCO
4
DELISTED
Patterson Companies, Inc.
PDCO
$53M 6.31%
1,225,000
+370,000
+43% +$17.7M
ELGX
5
DELISTED
Endologix Inc
ELGX
$49.7M 5.91%
405,000
– –
MDT icon
6
Medtronic
MDT
$107B
$46.9M 5.58%
700,000
+200,000
+40% +$14.7M
DGX icon
7
Quest Diagnostics
DGX
$23.2B
$43M 5.12%
700,000
– –
ITGR icon
8
Integer Holdings
ITGR
$3.38B
$39.5M 4.7%
767,900
-26,286
-3% -$1.31M
BDX icon
9
Becton Dickinson
BDX
$44.1B
$36.5M 4.34%
281,875
-128,125
-31% -$17.9M
NXTM
10
DELISTED
NxStage Medical Inc.
NXTM
$31.5M 3.75%
2,000,000
+325,000
+19% +$5.21M
MDRX
11
DELISTED
Veradigm Inc. Common Stock
MDRX
$26.7M 3.17%
2,150,000
+375,000
+21% +$5.16M
IMPR
12
DELISTED
IMPRIVATA, INC COM
IMPR
$25.3M 3.01%
1,425,000
+400,000
+39% +$7.15M
ALKS icon
13
Alkermes
ALKS
$8.66B
$21.4M 2.55%
365,000
-35,000
-9% -$2.31M
MRK icon
14
CALL
Merck
MRK
$315B
$19.8M 2.35%
+419,200
New +$22.3M
ATRC icon
15
AtriCure
ATRC
$1.8B
$18.1M 2.15%
825,000
-60,000
-7% -$1.5M
LMNX
16
DELISTED
Luminex Corp
LMNX
$16.1M 1.91%
950,000
-50,000
-5% -$904K
BIO icon
17
Bio-Rad Laboratories Class A
BIO
$8.05B
$14.8M 1.76%
110,000
-11,050
-9% -$1.59M
PRGO icon
18
CALL
Perrigo
PRGO
$1.54B
$12.6M 1.5%
80,000
+27,000
+51% +$4.95M
CORI
19
DELISTED
Corium International, Inc.
CORI
$12.4M 1.47%
1,325,000
+605,615
+84% +$7.25M
TEVA icon
20
CALL
Teva Pharmaceuticals
TEVA
$37.5B
$11.3M 1.34%
+200,000
New +$13M
SRGA
21
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$11.1M 1.32%
65,000
-1,667
-3% -$319K
AMRN
22
Amarin Corp
AMRN
$297M
$11M 1.31%
285,000
+123,765
+77% +$5.62M
AMGN icon
23
Amgen
AMGN
$201B
$10.4M 1.23%
+75,000
New +$11.8M
SPNC
24
DELISTED
Spectranetics Corp
SPNC
$9.26M 1.1%
785,000
-265,000
-25% -$4.75M
PRGO icon
25
Perrigo
PRGO
$1.54B
$7.86M 0.94%
50,000
– –
1
2

Similar funds

RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
CWA
Constellation Wealth Advisors New York $903M AUM 2.38% 1-Year Est. Return
GHF
Good Harbor Financial Barrington, Illinois $916M AUM 5.96% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BMCMI
Bryn Mawr Capital Management Inc Bryn Mawr, Pennsylvania $577M AUM 6.5% 1-Year Est. Return
GACM
Green Arrow Capital Management New York $535M AUM 14.21% 1-Year Est. Return
AH
Achievement Holdings Chicago, Illinois $1.2B AUM 9.2% 1-Year Est. Return

Tamarack Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Tamarack Capital Management held 42 positions worth $840M, down 3.4% from $870M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Tamarack Capital Management deployed $55.4M of net new capital in Q3 2015, opening 7 new positions and adding to 11 existing holdings. Its largest new stake was Amgen: 75,000 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 57% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Becton Dickinson, an estimated $17.9M trimmed.

  • Tamarack Capital Management's largest Q3 2015 buy was Amgen: 75,000 shares worth $10.4M.
  • Tamarack Capital Management added most to Patterson Companies, Inc. in Q3 2015, an estimated $17.7M increase.
  • Tamarack Capital Management's biggest Q3 2015 reduction was Becton Dickinson, cutting an estimated $17.9M.
  • Tamarack Capital Management fully exited MiMedx Group in Q3 2015, selling an estimated $15.1M.
  • Tamarack Capital Management's ten largest holdings make up 71% of its $840M portfolio in Q3 2015.
  • Tamarack Capital Management opened 7 new positions and closed 10 in Q3 2015.
  • Tamarack Capital Management's portfolio value fell 3.4% quarter-over-quarter to $840M.

Based on Tamarack Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.